Baron AT - Search Results

1

EGF/ErbB receptor family in ovarian cancer.

Maihle NJ, Baron AT, Barrette BA, Boardman CH, Christensen TA, Cora EM, Faupel-Badger JM, Greenwood T, Juneja SC, Lafky JM, Lee H, Reiter JL, Podratz KC. Maihle NJ, et al. Among authors: baron at. Cancer Treat Res. 2002;107:247-58. doi: 10.1007/978-1-4757-3587-1_11. Cancer Treat Res. 2002. PMID: 11775453 Review.

2

Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.

Baron AT, Cora EM, Lafky JM, Boardman CH, Buenafe MC, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ. Baron AT, et al. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):103-13. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12582019

3

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole.

Lafky JM, Baron AT, Cora EM, Hillman DW, Suman VJ, Perez EA, Ingle JN, Maihle NJ. Lafky JM, et al. Among authors: baron at. Cancer Res. 2005 Apr 15;65(8):3059-62. doi: 10.1158/0008-5472.CAN-05-0067. Cancer Res. 2005. PMID: 15833834

4

Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer.

Lafky JM, Wilken JA, Baron AT, Maihle NJ. Lafky JM, et al. Among authors: baron at. Biochim Biophys Acta. 2008 Apr;1785(2):232-65. doi: 10.1016/j.bbcan.2008.01.001. Epub 2008 Feb 7. Biochim Biophys Acta. 2008. PMID: 18291115 Review.

5

Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.

Baron AT, Lafky JM, Boardman CH, Cora EM, Buenafe MC, Liu D, Rademaker A, Fishman DA, Podratz KC, Reiter JL, Maihle NJ. Baron AT, et al. Cancer Treat Res. 2009;149:189-202. doi: 10.1007/978-0-387-98094-2_9. Cancer Treat Res. 2009. PMID: 19763437 Review. No abstract available.

6

Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.

Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ. Baron AT, et al. Cancer Epidemiol Biomarkers Prev. 1999 Feb;8(2):129-37. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10067810

7

A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women.

Baron AT, Lafky JM, Suman VJ, Hillman DW, Buenafe MC, Boardman CH, Podratz KC, Perez EA, Maihle NJ. Baron AT, et al. Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1175-85. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11700266

8

Generation and characterization of polyclonal antibodies specific for human p110 sEGFR.

Christensen TA, Reiter JL, Baron AT, Maihle NJ. Christensen TA, et al. Among authors: baron at. Hybrid Hybridomics. 2002 Jun;21(3):183-9. doi: 10.1089/153685902760173908. Hybrid Hybridomics. 2002. PMID: 12165144

9

Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.

Baron AT, Boardman CH, Lafky JM, Rademaker A, Liu D, Fishman DA, Podratz KC, Maihle NJ. Baron AT, et al. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):306-18. doi: 10.1158/1055-9965.EPI-04-0423. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15734951

10

Soluble epidermal growth factor receptor acridinium-linked immunosorbent assay.

Lafky JM, Baron AT, Maihle NJ. Lafky JM, et al. Among authors: baron at. Methods Mol Biol. 2006;327:39-47. doi: 10.1385/1-59745-012-X:39. Methods Mol Biol. 2006. PMID: 16780211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters